NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free HCAT Stock Alerts $7.01 +0.23 (+3.39%) (As of 01:33 PM ET) Add Compare Share Share Today's Range$6.72▼$7.0350-Day Range$5.53▼$8.9152-Week Range$5.45▼$14.37Volume141,952 shsAverage Volume635,846 shsMarket Capitalization$413.80 millionP/E RatioN/ADividend YieldN/APrice Target$12.18 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Health Catalyst alerts: Email Address Health Catalyst MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.73 Rating ScoreUpside/Downside81.0% Upside$12.18 Price TargetShort InterestHealthy3.27% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment0.36Based on 18 Articles This WeekInsider TradingSelling Shares$12,251 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.47) to ($0.28) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.59 out of 5 starsMedical Sector84th out of 929 stocksComputer Programming, Data Processing, & Other Computer Related Industry6th out of 59 stocks 4.4 Analyst's Opinion Consensus RatingHealth Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageHealth Catalyst has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Health Catalyst's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.27% of the outstanding shares of Health Catalyst have been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Health Catalyst has recently increased by 9.66%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHealth Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.Environmental SustainabilityThe Environmental Impact score for Health Catalyst is -0.91. Previous Next 2.4 News and Social Media Coverage News SentimentHealth Catalyst has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Health Catalyst this week, compared to 3 articles on an average week.Search Interest7 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. This is a decrease of -57% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,251.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Health Catalyst's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.47) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -3.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -3.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Health Catalyst's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. About Health Catalyst Stock (NASDAQ:HCAT)Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.Read More HCAT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HCAT Stock News HeadlinesApril 18, 2024 | insidertrades.comHealth Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 2,005 SharesMay 15 at 5:12 AM | americanbankingnews.comReviewing MicroCloud Hologram (NASDAQ:HOLO) & Health Catalyst (NASDAQ:HCAT)May 14 at 7:06 AM | americanbankingnews.comWells Fargo & Company Trims Health Catalyst (NASDAQ:HCAT) Target Price to $13.00May 13 at 7:45 AM | markets.businessinsider.comStifel Nicolaus Keeps Their Hold Rating on Health Catalyst (HCAT)May 11, 2024 | finance.yahoo.comHealth Catalyst First Quarter 2024 Earnings: EPS Misses ExpectationsMay 10, 2024 | finanznachrichten.deHealth Catalyst, Inc.: Health Catalyst Reports First Quarter 2024 ResultsMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Health Catalyst Amidst Solid Financials and Strong Prospects for New Ignite PlatformMay 10, 2024 | finance.yahoo.comHealth Catalyst Inc (HCAT) Q1 2024 Earnings: Modest Revenue Growth and Strategic Financial ...May 10, 2024 | markets.businessinsider.comKeyBanc Keeps Their Hold Rating on Health Catalyst (HCAT)May 9, 2024 | investorplace.comHCAT Stock Earnings: Health Catalyst Beats EPS, Misses Revenue for Q1 2024May 9, 2024 | finance.yahoo.comHealth Catalyst (NASDAQ:HCAT) Posts Q1 Sales In Line With Estimates But Quarterly Guidance UnderwhelmsMay 9, 2024 | globenewswire.comHealth Catalyst Reports First Quarter 2024 ResultsMay 9, 2024 | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by AnalystsMay 8, 2024 | markets.businessinsider.comHealth Catalyst earnings: here's what Wall Street expectsMay 8, 2024 | finance.yahoo.comWhat To Expect From Health Catalyst's (HCAT) Q1 EarningsMay 8, 2024 | yahoo.comCentral Ohio Technical College unveils mascot TC the Cat, representing TechCare CatalystApril 30, 2024 | msn.comNew Recommendation (April 30, 2024)April 27, 2024 | msn.comCustom-made catalyst leads to longer-lasting and more sustainable green hydrogen productionApril 24, 2024 | globenewswire.comHealth Catalyst to Announce First Quarter 2024 Operating Results and Host Conference Call on Thursday, May 9, 2024April 22, 2024 | finance.yahoo.comData Analytics Stocks Q4 Earnings: Palantir (NYSE:PLTR) Best of the BunchApril 13, 2024 | seekingalpha.comOscar Health: Strong Industry Catalyst With Margin Expansion PotentialMarch 17, 2024 | finance.yahoo.comHCAT Dec 2024 10.000 putMarch 17, 2024 | finance.yahoo.comHCAT Apr 2024 7.500 putMarch 16, 2024 | finance.yahoo.comHCAT Apr 2024 10.000 callMarch 16, 2024 | finance.yahoo.comHCAT Dec 2024 17.500 callSee More Headlines Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today5/16/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Computer programming, data processing, & other computer related Sub-IndustryN/A Current SymbolNASDAQ:HCAT CUSIPN/A CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$12.18 High Stock Price Target$16.00 Low Stock Price Target$8.00 Potential Upside/Downside+79.7%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($1.85) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-118,150,000.00 Net Margins-35.56% Pretax Margin-35.43% Return on Equity-11.86% Return on Assets-6.26% Debt Debt-to-Equity RatioN/A Current Ratio4.31 Quick Ratio4.42 Sales & Book Value Annual Sales$295.94 million Price / Sales1.35 Cash FlowN/A Price / Cash FlowN/A Book Value$6.05 per share Price / Book1.12Miscellaneous Outstanding Shares59,030,000Free Float57,440,000Market Cap$400.22 million OptionableOptionable Beta1.32 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Daniel D. Burton (Age 48)CEO & Director Comp: $158.9kMr. Daniel H. Orenstein (Age 54)Senior Advisor Comp: $356.56kMr. Kevin Freeman (Age 51)Chief Commercial Officer Comp: $405.9kMr. Jason Alger (Age 40)CFO & Chief Accounting Officer Mr. Daniel LeSueurChief Operating OfficerMr. Dave RossChief Technology OfficerMr. Adam BrownSenior Vice President of Investor Relations and Financial Planning & AnalysisMr. Benjamin LandryGeneral Counsel & Secretary of the BoardMs. Tarah Neujahr BryanChief Marketing & Communications OfficerMr. Kyle J. SalyersChief Strategy Officer & Senior VP of Corporate DevelopmentMore ExecutivesKey CompetitorsShattuck LabsNASDAQ:STTKOraSure TechnologiesNASDAQ:OSURVerrica PharmaceuticalsNASDAQ:VRCAKorro BioNASDAQ:KRRONeurogeneNASDAQ:NGNEView All CompetitorsInsiders & InstitutionsFirst Light Asset Management LLCSold 279,794 shares on 5/15/2024Ownership: 1.245%Public Employees Retirement System of OhioSold 3,469 shares on 5/15/2024Ownership: 0.136%Price T Rowe Associates Inc. MDBought 2,831 shares on 5/15/2024Ownership: 0.084%Public Employees Retirement Association of ColoradoSold 1,551 shares on 5/15/2024Ownership: 0.026%CANADA LIFE ASSURANCE CoSold 2,390 shares on 5/14/2024Ownership: 0.071%View All Insider TransactionsView All Institutional Transactions HCAT Stock Analysis - Frequently Asked Questions Should I buy or sell Health Catalyst stock right now? 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HCAT shares. View HCAT analyst ratings or view top-rated stocks. What is Health Catalyst's stock price target for 2024? 11 analysts have issued 12 month price targets for Health Catalyst's stock. Their HCAT share price targets range from $8.00 to $16.00. On average, they expect the company's share price to reach $12.18 in the next twelve months. This suggests a possible upside of 81.0% from the stock's current price. View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts. How have HCAT shares performed in 2024? Health Catalyst's stock was trading at $9.26 at the beginning of 2024. Since then, HCAT stock has decreased by 27.3% and is now trading at $6.73. View the best growth stocks for 2024 here. When is Health Catalyst's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our HCAT earnings forecast. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) announced its earnings results on Thursday, February, 22nd. The company reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.06. The firm had revenue of $75.08 million for the quarter, compared to the consensus estimate of $73.67 million. Health Catalyst had a negative trailing twelve-month return on equity of 11.86% and a negative net margin of 35.56%. What ETF holds Health Catalyst's stock? Fidelity Digital Health ETF holds 12,903 shares of HCAT stock, representing 0.88% of its portfolio. What guidance has Health Catalyst issued on next quarter's earnings? Health Catalyst updated its second quarter 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $73.5 million-$76.5 million, compared to the consensus revenue estimate of $75.6 million. What is Dan Burton's approval rating as Health Catalyst's CEO? 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL). When did Health Catalyst IPO? Health Catalyst (HCAT) raised $129 million in an initial public offering on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Health Catalyst's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.58%), Nepsis Inc. (1.98%), First Light Asset Management LLC (1.24%), Acadian Asset Management LLC (1.23%), ClariVest Asset Management LLC (0.48%) and Essex Investment Management Co. LLC (0.42%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn and Paul Horstmeier. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HCAT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.